<DOC>
	<DOCNO>NCT00776373</DOCNO>
	<brief_summary>Assess safety , tolerability efficacy rapamycin combination HiVAC relapse refractory patient aggressive lymphoid malignancy .</brief_summary>
	<brief_title>Rapamycin With High-Dose Etoposide Cytarabine Relapsed/Refractory Aggressive Lymphoid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Advanced lymphoid leukemia ( primary refractory ALL ; Relapsed ALL ; CML lymphoid accelerate phase blast crisis ; relapse refractory Burkitt 's lymphoma ; relapse refractory Tcell adult leukemia/lymphoma ; relapse refractory lymphoblastic lymphoma &gt; = 18 &lt; = 65 year age ECOG performance status 0 , 1 Life expectancy &gt; = 4 week Able consume oral medication Required initial laboratory value : Creatinine &lt; = 2.0mg/dL , total direct bilirubin &lt; = 1.5 mg/dL , SGPT ( ALT ) &lt; =ULN , glucose &lt; 200 mg/dL , negative pregnancy test woman child bear potential Subjects must receive chemotherapy agent ( except Hydroxyurea ) Subjects must receive highdose AraC within 6 month relapse Subjects must receive growth factor , except erythropoietin No currently active second malignancy nonmelanoma skin cancers No subject uncontrolled high blood pressure , unstable angina , symptomatic congestive heart failure , MI within last 6 month serious uncontrolled cardiac arrhythmia Subjects take Carbamazepine , Rifabutin , Rifampin , Rifapentine , St. John 's wort , Clarithromycin , Cyclosporine , Diltiazem , Erythromycin , Telithromycin , Verapamil , Tacrolimus Known HIV positivity AIDSrelated illness Evidence cerebellar dysfunction prior history cerebellar dysfunction AraC administration Pregnant lactate Uncontrolled infection Taking fluconazole , voriconazole , itraconazole ketoconazole currently within one week study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>ALL</keyword>
	<keyword>Burkitt 's Lymphoma</keyword>
	<keyword>Adult T-Cell leukemia/lymphoma</keyword>
	<keyword>Lymphoblastic leukemia</keyword>
	<keyword>CML lymphoid blast crisis patient</keyword>
	<keyword>HiVAC</keyword>
	<keyword>Rapamycin</keyword>
</DOC>